Our research of β-catenin pathways in HBL patients revealed that the β-catenin-TCF4-CEGRs/ALCDs pathway accelerates the proliferation of cancer cells and increases the expression of many oncogenes, including AFP and GPC3. Here, TCF4 is linked to hepatoblastoma.